1 MONTELUKAST SODIUM | 380 of 4500 | 3690 prescriptions Less than 1% of all prescriptions | 3260 | 1340 patients 48% of all patients | 1170 patients 42% of all patients | |
2 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 50 of 3370 | 2370 prescriptions Less than 1% of all prescriptions | 2090 | 850 patients 30% of all patients | < 11 | |
3 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 760 of 4230 | 1750 prescriptions Less than 1% of all prescriptions | 1510 | 570 patients 20% of all patients | < 11 | |
4 FLUTICASONE PROPIONATE | 290 of 3510 | 1320 prescriptions Less than 1% of all prescriptions | | 640 patients 23% of all patients | < 11 | |
5 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 1080 of 4560 | 1180 prescriptions Less than 1% of all prescriptions | 870 | 360 patients 13% of all patients | < 11 | |
6 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 530 of 4380 | 1160 prescriptions Less than 1% of all prescriptions | 960 | 410 patients 15% of all patients | < 11 | |
7 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 510 of 3700 | 1080 prescriptions Less than 1% of all prescriptions | 900 | 290 patients 10% of all patients | < 11 | |
8 OMEPRAZOLE | 250 of 1560 | 610 prescriptions Less than 1% of all prescriptions | | 280 patients 10% of all patients | < 11 | |
9 PROAIR HFA (ALBUTEROL SULFATE) | 740 of 4320 | 930 prescriptions Less than 1% of all prescriptions | 790 | 600 patients 21% of all patients | < 11 | |
10 VENTOLIN HFA (ALBUTEROL SULFATE) | 1090 of 4490 | 690 prescriptions Less than 1% of all prescriptions | 540 | 390 patients 14% of all patients | < 11 | |
11 SPIRIVA (TIOTROPIUM BROMIDE) | 890 of 4040 | 570 prescriptions Less than 1% of all prescriptions | 570 | 110 patients 4% of all patients | 110 patients 4% of all patients | |
12 FLOVENT HFA (FLUTICASONE PROPIONATE) | 160 of 1360 | 430 prescriptions Less than 1% of all prescriptions | 250 | 110 patients 4% of all patients | < 11 | |
13 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 420 of 2150 | 420 prescriptions Less than 1% of all prescriptions | | 220 patients 8% of all patients | < 11 | |
14 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 1390 of 3750 | 300 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
15 DALIRESP (ROFLUMILAST) | 500 of 1740 | 280 prescriptions Less than 1% of all prescriptions | 280 | < 11 | < 11 | |
16 SILDENAFIL (SILDENAFIL CITRATE) | 290 of 700 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 IPRATROPIUM BROMIDE | 370 of 1020 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 PREDNISONE | 1930 of 4670 | 410 prescriptions Less than 1% of all prescriptions | 290 | 190 patients 7% of all patients | < 11 | |
19 ELIQUIS (APIXABAN) | 300 of 870 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
20 MOMETASONE FUROATE | 160 of 400 | 180 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
21 OPSUMIT (MACITENTAN) | 190 of 520 | 230 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
22 AZITHROMYCIN | 1280 of 3840 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | A |
23 AZELASTINE HCL | 510 of 1300 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 METHYLPREDNISOLONE | 200 of 1270 | 730 prescriptions Less than 1% of all prescriptions | | 520 patients 19% of all patients | < 11 | |
25 LEVOFLOXACIN | 420 of 2450 | 480 prescriptions Less than 1% of all prescriptions | | 310 patients 11% of all patients | < 11 | A |
26 UPTRAVI (SELEXIPAG) | 190 of 250 | 120 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
27 ESBRIET (PIRFENIDONE) | 390 of 1250 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
28 AMOXICILLIN-CLAVULANATE POTASS (AMOXICILLIN/POTASSIUM CLAV) | 430 of 1570 | 180 prescriptions Less than 1% of all prescriptions | | 160 patients 6% of all patients | < 11 | A |
29 DOXYCYCLINE HYCLATE | 510 of 1340 | 120 prescriptions Less than 1% of all prescriptions | | 120 patients 4% of all patients | < 11 | A |